Retatrutide Results: 24% Weight Loss Timeline (2026)

Most people feel appetite changes in week 1 — but the 24% body weight loss takes a specific dose schedule. Week-by-week from phase 2 data.

Retatrutide delivers the most profound weight loss ever recorded in clinical trials — but the timeline isn’t instant. Here’s what actually happens week by week, based on Phase 2 trial data where participants lost an average of 24% of their body weight over 48 weeks.

This timeline is based on published clinical trial results, known mechanisms of triple receptor activation, and safety data from Phase 2 studies. Individual results vary based on starting weight, adherence to dosing protocols, and concurrent lifestyle factors.

Understanding the mechanism explains the timeline. Retatrutide activates three receptors simultaneously:

This cascade means appetite changes occur first (hours to days), while metabolic reprogramming and significant weight loss take weeks to months. The 24% weight loss seen in trials represents the cumulative effect of all three pathways working together over 48 weeks (Jastreboff et al., 2023).

The GLP-1 and GIP receptor activation begins immediately after the first injection. Gastric emptying slows dramatically, keeping food in the stomach longer. Satiety signals to the brain intensify, while the reward response to food decreases. These are acute pharmacological effects that don’t require metabolic adaptation.